MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, SYK made $25,116M in revenue. $3,246M in net income. Net profit margin of 12.92%.

Income Overview

Revenue
$25,116M
Net Income
$3,246M
Net Profit Margin
12.92%
EPS
$8.4
Unit: Million (M) dollars
Revenue Breakdown
    • US
    • Non Us
Revenue Breakdown
    • Medical
    • Traumaand Extremities
    • Endoscopy
    • Others
Revenue Breakdown
    • Med Surg And Neurotechnology
    • Orthopaedics
Revenue Breakdown
    • US
    • EMEA
    • Asia Pacific
    • Other Foreign Countries

Income Statement
2025-12-31
2024-12-31
2023-12-31
2022-12-31
Net sales
25,116 22,595 20,498 18,449
Cost of sales
9,051 8,155 7,440 6,871
Gross profit
16,065 14,440 13,058 11,578
Research, development and engineering expenses
1,623 1,466 1,388 1,454
Selling, general and administrative expenses
8,651 7,685 7,129 6,455
Recall charges, net
--18 -15
Amortization of intangible assets
732 623 635 627
Goodwill impairment
--0 216
Goodwill and other impairments
170 977 --
Total operating expenses
11,176 10,751 9,170 8,737
Operating income
4,889 3,689 3,888 2,841
Interest expense
607 ---
Other income
232 -197 -215 -158
Earnings before income taxes
4,514 3,492 3,673 2,683
Income taxes
1,268 499 508 325
Net earnings
3,246 2,993 3,165 2,358
Basic EPS
8.49 7.86 8.34 6.23
Diluted EPS
8.4 7.76 8.25 6.17
Basic Average Shares
382,200,000 381,000,000 379,600,000 378,200,000
Diluted Average Shares
386,500,000 385,600,000 383,700,000 382,200,000
Unit: Million (M) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Medical$3,510M (10.00%↑ Y/Y)Endoscopy$3,133M (12.21%↑ Y/Y)Instruments$2,562M (13.01%↑ Y/Y)Neuro Cranial$2,052M (16.52%↑ Y/Y)Neurovascular$1,048M (107.11%↑ Y/Y)Traumaand Extremities$2,926M (13.15%↑ Y/Y)Knees$1,924M (7.61%↑ Y/Y)Hips$1,137M (7.37%↑ Y/Y)Other Orthopaedics$596M (18.25%↑ Y/Y)Spine$118M (-75.87%↓ Y/Y)Neurovascular$920M (14.86%↑ Y/Y)Medical$694M (4.99%↑ Y/Y)Endoscopy$674M (12.90%↑ Y/Y)Instruments$621M (9.52%↑ Y/Y)Neuro Cranial$433M (15.47%↑ Y/Y)Traumaand Extremities$1,022M (10.97%↑ Y/Y)Knees$732M (11.08%↑ Y/Y)Hips$728M (12.87%↑ Y/Y)Other Orthopaedics$219M (5.29%↑ Y/Y)Spine$67M (-69.27%↓ Y/Y)Med Surg AndNeurotechnology$12,305M (17.00%↑ Y/Y)Orthopaedics And Spine$6,701M (4.28%↑ Y/Y)Med Surg AndNeurotechnology$3,342M (11.36%↑ Y/Y)Orthopaedics And Spine$2,768M (4.41%↑ Y/Y)US$19,006M (12.18%↑ Y/Y)Non Us$6,110M (8.10%↑ Y/Y)Net sales$25,116M (11.16%↑ Y/Y)Gross profit$16,065M (11.25%↑ Y/Y)Cost of sales$9,051M (10.99%↑ Y/Y)Operating income$4,889M (32.53%↑ Y/Y)Other income$232M (217.77%↑ Y/Y)Total operatingexpenses$11,176M (3.95%↑ Y/Y)Earnings before incometaxes$4,514M (29.27%↑ Y/Y)Interest expense$607M Selling, general andadministrative expenses$8,651M (12.57%↑ Y/Y)Research, development andengineering expenses$1,623M (10.71%↑ Y/Y)Amortization of intangibleassets$732M (17.50%↑ Y/Y)Goodwill and otherimpairments$170M (-82.60%↓ Y/Y)Net earnings$3,246M (8.45%↑ Y/Y)Income taxes$1,268M (154.11%↑ Y/Y)

STRYKER CORP (SYK)

STRYKER CORP (SYK)